Human studies
Trials in people, graded by size, design, outcomes, and maturity.
Peptide info online is a mess of hype and fear.
24 peptide evidence records51 linked sources129 reviewed answers
We grade the actual evidence—human and animal studies separately—and link every source so you can check our work.
HOW EVIDENCE IS GRADED
Trials in people, graded by size, design, outcomes, and maturity.
Laboratory findings stay separate from evidence in people.
The grades measure how much research exists—not whether a peptide works or whether it is right for you.
WHAT CHANGED
Every new study, FDA action, sport-rule change, and record update shows its date and source.
NEWS & ANALYSIS
Seventeen revised draft product-specific guidances explain the evidence FDA expects for certain generic peptide applications.
Lilly reported positive topline TRIUMPH-2 and TRIUMPH-3 results. The data are important, but they are not an FDA approval.
The agency restated the legal boundary between limited compounding exceptions and routine copies of approved GLP-1 medicines.
RECENT RECORD UPDATES
Added stable source IDs and original URLs to the matrix export, plus a normalized source-library export.
Added a page for every source, showing exactly which peptide records cite it.
Replaced a retired FDA mirror URL with the live U.S. Department of Justice record and corrected the publisher classification.
BROWSE BY GOAL
Approved medicines and the investigational ones behind them
02What the healing claims are actually based on
03Peptides that raise growth hormone, and what that does and doesn't mean
04Aging research, minus the anti-aging promises
05Nootropic peptides and where the evidence stops
06Immunity claims, graded
POPULAR COMPARISONS
ASK, WITH SOURCES
ABOUT
Peptide research is scattered — buried in journal papers, filtered through vendor marketing, or passed around forums as anecdote. PeptideAgent was built to close that gap: every published page is organized from primary sources, verified, and owned by PeptideAgent from first draft to every update.